• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Drug-eluting coronary-artery stents.

作者信息

Stefanini Giulio G, Holmes David R

机构信息

Department of Cardiology, Bern University Hospital, Bern, Switzerland.

出版信息

N Engl J Med. 2013 Jan 17;368(3):254-65. doi: 10.1056/NEJMra1210816.

DOI:10.1056/NEJMra1210816
PMID:23323902
Abstract
摘要

相似文献

1
Drug-eluting coronary-artery stents.药物洗脱冠状动脉支架
N Engl J Med. 2013 Jan 17;368(3):254-65. doi: 10.1056/NEJMra1210816.
2
A prospective evaluation of the safety and efficacy of TAXUS Element paclitaxel-eluting coronary stent implantation for the treatment of de novo coronary artery lesions in small vessels: the PERSEUS Small Vessel trial.TAXUS Element 紫杉醇洗脱冠状动脉支架治疗小血管初发冠状动脉病变的安全性和有效性的前瞻性评估：PERSEUS 小血管试验。
EuroIntervention. 2011 Mar;6(8):920-7, 1-2. doi: 10.4244/EIJV6I8A161.
3
The euros and sense of stents: do we get value for money?支架的成本效益：我们物有所值吗？
J Cardiovasc Med (Hagerstown). 2011 Dec;12(12):878-82. doi: 10.2459/JCM.0b013e32834da507.
4
Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.经皮冠状动脉介入治疗的最新进展：药物洗脱支架的演变，聚焦于XIENCE V药物洗脱支架。
Coron Artery Dis. 2010 Jan;21(1):46-56. doi: 10.1097/MCA.0b013e328333f550.
5
[Drug-eluting coronary stents].药物洗脱冠状动脉支架
Internist (Berl). 2014 Jan;55(1):103-6. doi: 10.1007/s00108-013-3402-9.
6
Stent thrombosis following 2 drug-eluting stent implantations for coronary bifurcation lesion: a single-center analysis.冠状动脉分叉病变行 2 枚药物洗脱支架置入术后支架血栓形成：单中心分析。
J Interv Cardiol. 2010 Aug;23(4):346-51. doi: 10.1111/j.1540-8183.2010.00565.x.
7
Intraoperative thrombosis of right coronary artery drug-eluting stent after 2 years of dual antiplatelet therapy.双联抗血小板治疗2年后右冠状动脉药物洗脱支架术中血栓形成
Semin Cardiothorac Vasc Anesth. 2011 Mar-Jun;15(1-2):40-3. doi: 10.1177/1089253211411105.
8
Cost-effectiveness of everolimus- versus paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization (from the SPIRIT-IV Trial).经皮冠状动脉血运重建术患者中依维莫司洗脱支架与紫杉醇洗脱支架的成本效益比较（来自 SPIRIT-IV 试验）。
Am J Cardiol. 2012 Sep 15;110(6):765-70. doi: 10.1016/j.amjcard.2012.05.006. Epub 2012 May 30.
9
Acute ST-elevation myocardial infarction 6 years following a sirolimus-eluting stent secondary to complete stent fracture.西罗莫司洗脱支架完全断裂继发急性ST段抬高型心肌梗死6年后
J Invasive Cardiol. 2012 Apr;24(4):E64-6.
10
Peeling-off labels mounting evidence for benefit of drug-eluting stents with off-label use.标签剥离凸显了药物洗脱支架非标签使用有益的越来越多的证据。
J Am Coll Cardiol. 2007 Nov 20;50(21):2037-8. doi: 10.1016/j.jacc.2007.08.020. Epub 2007 Nov 5.

引用本文的文献

1
Controversies in Antithrombotic Therapy for Patients With Coronary Artery Disease and Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Literature Review.接受经皮冠状动脉介入治疗的冠心病合并心房颤动患者抗栓治疗的争议：文献综述
Clin Med Insights Cardiol. 2025 Aug 30;19:11795468251361209. doi: 10.1177/11795468251361209. eCollection 2025.
2
Comparative Efficacy and Long-Term Outcomes of Drug-Eluting Stents vs. Bare-Metal Stents in Coronary Artery Disease: A Systematic Review.药物洗脱支架与裸金属支架治疗冠状动脉疾病的疗效比较及长期预后：一项系统评价
Cureus. 2025 Jun 23;17(6):e86617. doi: 10.7759/cureus.86617. eCollection 2025 Jun.
3
Comparison of the Efficacy of Everolimus-Eluting Stents and Paclitaxel-Eluting Balloon Angioplasty for Coronary In-Stent Restenosis: A Systematic Review and Meta-Analysis.
依维莫司洗脱支架与紫杉醇洗脱球囊血管成形术治疗冠状动脉支架内再狭窄疗效的比较：一项系统评价和荟萃分析
Rev Cardiovasc Med. 2025 Jun 16;26(6):26387. doi: 10.31083/RCM26387. eCollection 2025 Jun.
4
Long-term outcomes of biodegradable versus 2nd generation durable polymer drug-eluting stents in PCI: Protocol for a systematic review and meta-analysis.经皮冠状动脉介入治疗中可生物降解与第二代耐用聚合物药物洗脱支架的长期疗效：系统评价与荟萃分析方案
PLoS One. 2025 Mar 19;20(3):e0319946. doi: 10.1371/journal.pone.0319946. eCollection 2025.
5
Study on the potential clinical significance of subclinical stent edge effects after drug-eluting stent implantation.药物洗脱支架植入术后亚临床支架边缘效应的潜在临床意义研究
Sci Rep. 2025 Mar 10;15(1):8258. doi: 10.1038/s41598-024-81329-7.
6
Clinical outcomes of rotational atherectomy followed by cutting balloon for calcified coronary lesions.旋磨术联合切割球囊治疗钙化性冠状动脉病变的临床结果
Coron Artery Dis. 2025 Sep 1;36(6):496-503. doi: 10.1097/MCA.0000000000001515. Epub 2025 Feb 21.
7
Recent Advances in the Treatment of Coronary In-Stent Restenosis.冠状动脉支架内再狭窄治疗的最新进展
Rev Cardiovasc Med. 2024 Dec 6;25(12):433. doi: 10.31083/j.rcm2512433. eCollection 2024 Dec.
8
Bibliometrics of trends in global research on the roles of stem cells in myocardial fibrosis therapy.全球干细胞在心肌纤维化治疗中作用的研究趋势的文献计量学
World J Stem Cells. 2024 Dec 26;16(12):1086-1105. doi: 10.4252/wjsc.v16.i12.1086.
9
Safety and Efficacy of Two Ultrathin Biodegradable Polymer Sirolimus-Eluting Stents in Real-World Practice: Genoss DES Stents Versus Orsiro Stents From a Prospective Registry.两种超薄可生物降解聚合物西罗莫司洗脱支架在实际临床中的安全性和有效性：一项前瞻性注册研究中Genoss药物洗脱支架与Orsiro支架的对比
Clin Cardiol. 2024 Dec;47(12):e70060. doi: 10.1002/clc.70060.
10
Mechanisms of ferroptosis and glucagon-like peptide-1 receptor agonist in post-percutaneous coronary intervention restenosis.铁死亡机制与胰高血糖素样肽-1受体激动剂在经皮冠状动脉介入治疗后再狭窄中的作用
Mol Cell Biochem. 2025 Mar;480(3):1465-1480. doi: 10.1007/s11010-024-05118-6. Epub 2024 Sep 16.